REFERENCES

1. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R,Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829 –1839.
2. 2. Barter P, Gotto AM, LaRosa JC, Maroni J, M. Szarek M, Grundy SM, Kastelein JJ, V. Bittner V, Fruchart JC. Treating to new targets investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357:1301–1310.
3. Weisberg SP, McCann, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
4. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein-1 in Obesity and insulin resistance”, Proc. Natl. Acad. Sci. U. S. A, 2003; 100: 7265-7270
5. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007–2011
6. VanLeeuwen M, Van Rijswijk M. Acute phase proteins in the monitoring of inflammatory disorders. BaillieresClin Rheumatol.1994;8(3):531–52.
7. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.
8. Paul M. Ridker, MD; Robert J. Glynn, ScD; Charles H. Hennekens, MD. C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction.Circulation. 1998;97:2007-2011 .
9.  Ross R, Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126.
10. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med. 1999;130:933–937.
11. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96–102.
12. Ridker PM, Hennekens CH, Buring JE, et al. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843.
13. Kuller LH, Tracy RP, Shaten J, et al, for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol.1996;144:537–547.
14. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979.
15. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. ArteriosclerThrombVasc Biol. 1997;17:1121–1127.
16. AfreenArshadChoudhry ,KrishnanandaPrabhu. An Association of High Sensitive C Reactive Protein and Lipid Profile Parameters in South Indian Population.International Journal of Scientific and Research Publications. July 2013; 3(7):1-3 AfreenArshadChoudhry ,KrishnanandaPrabhu. An Association of High Sensitive C Reactive Protein and Lipid Profile Parameters in South Indian Population.International Journal of Scientific and Research Publications. July 2013; 3(7):1-3